Peptide autoinjector manufacturing demands precise formulation-device coordination, rigorous Cpk-driven quality control, and FAT validation for reliable, compliant dosing.
Ajoy Koppolu
Advertisement
Ajoy Koppolu, PhD, MBA; Pharmaceutical Industry Consultant, NJ 08823
Corresponding email: [email protected]
Articles by Ajoy Koppolu
The established safety profiles, dosing regimens, and manufacturing pathways of repurposed generics can significantly shorten timelines and reduce costs as alternative cancer therapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
3
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5